Cargando…
Failure of tocilizumab in treating two patients with refractory SAPHO syndrome: a case report
Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is a rare autoinflammatory disease with no standard treatment. Interleukin (IL)-6 inhibitors represent a novel therapeutic option for rheumatoid arthritis and some autoinflammatory diseases. However, the clinical utility of IL-...
Autores principales: | Sun, Xiao-Chuan, Liu, Shuang, Li, Chen, Zhang, Shuo, Wang, Mu, Shi, Xiao-Hua, Hao, Wei-Xin, Zhang, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300969/ https://www.ncbi.nlm.nih.gov/pubmed/30428761 http://dx.doi.org/10.1177/0300060518806105 |
Ejemplares similares
-
Case report: successful treatment of refractory SAPHO syndrome with the JAK inhibitor tofacitinib
por: Yang, Qiao, et al.
Publicado: (2018) -
Mandibular involvement in SAPHO syndrome: a retrospective study
por: Wang, Mu, et al.
Publicado: (2020) -
SAPHO syndrome: a review
por: Rukavina, Iva
Publicado: (2015) -
Systemic Amyloidosis with Renal Failure: A Challenging Diagnosis of SAPHO Syndrome
por: Correia, Cristina Pires, et al.
Publicado: (2019) -
Sapho : mceurs parisiennes
por: Daudet, Alphonse, 1840-1897